Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
In the latest session, Origin Materials Inc (NASDAQ: ORGN) closed at $0.21 down -6.71% from its previous closing price of $0.23. In other words, the price has decreased by -$6.71 from its previous closing price. On the day, 2.01 million shares were traded. ORGN stock price reached its highest trading level at $0.2295 during the session, while it also had its lowest trading level at $0.21.
Ratios:
For a deeper understanding of Origin Materials Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.28 and its Current Ratio is at 6.33. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In the most recent recommendation for the company, BofA Securities on January 14, 2025, Downgraded its rating to Underperform and sets its target price to $1.50 from $2.50 previously.
On August 16, 2024, BofA Securities Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $1.35 to $3.
Craig Hallum Downgraded its Buy to Hold on August 11, 2023, while the target price for the stock was maintained at $2.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 26 ’25 when MATTHEW PLAVAN bought 40,000 shares for $0.20 per share.
Lee Joshua C. sold 35,000 shares of ORGN for $6,912 on Dec 29 ’25. The General Counsel now owns 606,884 shares after completing the transaction at $0.20 per share. On Dec 24 ’25, another insider, Lee Joshua C., who serves as the General Counsel of the company, sold 29,000 shares for $0.23 each. As a result, the insider received 6,609 and left with 641,884 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ORGN now has a Market Capitalization of 32595450 and an Enterprise Value of -16925530. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.30 while its Price-to-Book (P/B) ratio in mrq is 0.11. Its current Enterprise Value per Revenue stands at -0.674 whereas that against EBITDA is 0.321.
Stock Price History:
The Beta on a monthly basis for ORGN is 0.98, which has changed by -0.8043478 over the last 52 weeks, in comparison to a change of 0.1877265 over the same period for the S&P500. Over the past 52 weeks, ORGN has reached a high of $1.22, while it has fallen to a 52-week low of $0.19. The 50-Day Moving Average of the stock is -49.12%, while the 200-Day Moving Average is calculated to be -61.98%.
Shares Statistics:
For the past three months, ORGN has traded an average of 1.77M shares per day and 3195470 over the past ten days. A total of 150.53M shares are outstanding, with a floating share count of 140.40M. Insiders hold about 9.55% of the company’s shares, while institutions hold 11.00% stake in the company. Shares short for ORGN as of 1765756800 were 4123860 with a Short Ratio of 2.32, compared to 1763078400 on 3601424. Therefore, it implies a Short% of Shares Outstanding of 4123860 and a Short% of Float of 2.77.
